Dobutamine
Dobutamine (dobutamine) is a small molecule pharmaceutical. Dobutamine was first approved as Dobutrex on 1982-01-01. It is used to treat low cardiac output in the USA. The pharmaceutical is active against beta-1 adrenergic receptor.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
Therapeutic Area | MeSH |
|---|---|
| cardiovascular diseases | D002318 |
| signs and symptoms pathological conditions | D013568 |
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| dobutamine | ANDA | 2024-07-02 |
| dobutamine hydrochloride | New Drug Application | 2024-01-30 |
| dobutamine hydrochloride in dextrose | New Drug Application | 2023-09-08 |
| dobutamine in dextrose | New Drug Application | 2024-06-20 |
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
|---|---|---|---|
| low cardiac output | — | D002303 | — |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
Code | Description |
|---|---|
| C7553 | Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary angiography, imaging supervision and interpretation; with right and left heart catheterization including intraprocedural injection(s) for left ventriculography, when performed, catheter placement(s) in bypass graft(s) (internal mammary, free arterial, venous grafts) with bypass graft angiography with pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed |
| J1250 | Injection, dobutamine hydrochloride, per 250 mg |
| S9348 | Home infusion therapy, sympathomimetic/inotropic agent infusion therapy (e.g., dobutamine); administrative services, professional pharmacy services, care coordination, all necessary supplies and equipment (drugs and nursing visits coded separately), per diem |
Clinical
Clinical Trials
205 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Heart failure | D006333 | HP_0001635 | I50 | 2 | 5 | 7 | 7 | 23 | 42 |
| Coronary artery disease | D003324 | — | I25.1 | 1 | 1 | 3 | 1 | 24 | 30 |
| Shock | D012769 | — | R57.1 | 1 | 6 | 6 | 4 | 13 | 26 |
| Myocardial ischemia | D017202 | EFO_1001375 | I20-I25 | 1 | 1 | 5 | 1 | 14 | 22 |
| Coronary disease | D003327 | — | — | 1 | 1 | 5 | 1 | 10 | 18 |
| Heart diseases | D006331 | EFO_0003777 | I51.9 | 1 | 1 | 3 | 2 | 11 | 17 |
| Cardiogenic shock | D012770 | — | R57.0 | 1 | 3 | 3 | 4 | 6 | 16 |
| Septic shock | D012772 | — | A48.3 | — | 4 | 4 | 1 | 5 | 11 |
| Cardiomyopathies | D009202 | EFO_0000318 | I42 | 2 | 2 | 1 | 1 | 5 | 9 |
| Sepsis | D018805 | HP_0100806 | A41.9 | — | 2 | 2 | 2 | 3 | 8 |
Show 20 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Ischemia | D007511 | EFO_0000556 | — | — | — | 2 | — | 9 | 11 |
| Left ventricular dysfunction | D018487 | — | — | — | — | 1 | — | 6 | 7 |
| Cardiac surgical procedures | D006348 | — | — | — | — | 2 | — | 3 | 5 |
| Angina pectoris | D000787 | EFO_0003913 | I20 | 1 | — | 1 | — | 3 | 5 |
| Cardio-renal syndrome | D059347 | — | — | — | 1 | 1 | — | — | 2 |
| Tetralogy of fallot | D013771 | HP_0001636 | Q21.3 | — | — | 1 | — | 1 | 2 |
| Postoperative care | D011182 | — | — | — | — | 1 | — | — | 1 |
| Edema | D004487 | HP_0000969 | R60.9 | — | — | 1 | — | — | 1 |
| Dyspnea | D004417 | HP_0002094 | R06.0 | — | — | 1 | — | — | 1 |
| Systolic murmurs | D054160 | — | R01.1 | — | — | 1 | — | — | 1 |
Show 4 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Myocardial infarction | D009203 | EFO_0000612 | I21 | — | 1 | — | — | 6 | 7 |
| Wounds and injuries | D014947 | — | T14.8 | — | 2 | — | — | 4 | 6 |
| Infarction | D007238 | EFO_0009463 | — | — | 1 | — | — | 5 | 6 |
| Acute kidney injury | D058186 | HP_0001919 | N17 | — | 1 | — | — | 3 | 4 |
| Brain injuries | D001930 | — | S06.9 | — | 1 | — | — | 2 | 3 |
| Hypoxia | D000860 | HP_0012418 | R09.02 | — | 1 | — | — | 2 | 3 |
| Liver failure | D017093 | HP_0001399 | K72.9 | — | 1 | — | — | 1 | 2 |
| Acute liver failure | D017114 | HP_0004448 | — | — | 1 | — | — | 1 | 2 |
| Heart transplantation | D016027 | EFO_0010673 | — | — | 1 | — | — | 1 | 2 |
| Amyloidosis | D000686 | EFO_1001875 | E85 | 1 | 1 | — | — | 1 | 2 |
Show 9 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | — | 1 |
| Cardiac arrhythmias | D001145 | EFO_0004269 | I49.9 | 1 | — | — | — | — | 1 |
| Cardiac conduction system disease | D000075224 | — | I45.9 | 1 | — | — | — | — | 1 |
| Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | 1 | — | — | — | — | 1 |
| Asthma | D001249 | EFO_0000270 | J45 | 1 | — | — | — | — | 1 |
| Obstructive lung diseases | D008173 | HP_0006536 | — | 1 | — | — | — | — | 1 |
| Burns | D002056 | — | T30.0 | 1 | — | — | — | — | 1 |
| Hepatectomy | D006498 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Aortic valve stenosis | D001024 | HP_0001650 | — | — | — | — | — | 7 | 7 |
| Ventricular dysfunction | D018754 | — | — | — | — | — | — | 6 | 6 |
| Pathologic constriction | D003251 | — | — | — | — | — | — | 6 | 6 |
| Femoral fractures | D005264 | — | S72 | — | — | — | — | 4 | 4 |
| Bone fractures | D050723 | EFO_0003931 | T14.8 | — | — | — | — | 3 | 3 |
| Right ventricular dysfunction | D018497 | — | — | — | — | — | — | 3 | 3 |
| Chest pain | D002637 | HP_0100749 | R07.9 | — | — | — | — | 3 | 3 |
| Diabetes complications | D048909 | — | — | — | — | — | — | 2 | 2 |
| Cognitive dysfunction | D060825 | HP_0001268 | G31.84 | — | — | — | — | 2 | 2 |
| Brain ischemia | D002545 | EFO_0003883 | I67.82 | — | — | — | — | 2 | 2 |
Show 79 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Dobutamine |
| INN | dobutamine |
| Description | Dobutamine is a catecholamine that is 4-(3-aminobutyl)phenol in which one of the hydrogens attached to the nitrogen is substituted by a 2-(3,4-dihydroxyphenyl)ethyl group. A beta1-adrenergic receptor agonist that has cardiac stimulant action without evoking vasoconstriction or tachycardia, it is used as the hydrochloride to increase the contractility of the heart in the management of acute heart failure. It has a role as a cardiotonic drug, a sympathomimetic agent and a beta-adrenergic agonist. It is a secondary amine and a catecholamine. |
| Classification | Small molecule |
| Drug class | β1-agonist |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC(CCc1ccc(O)cc1)NCCc1ccc(O)c(O)c1 |
Identifiers
| PDB | — |
| CAS-ID | 34368-04-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL926 |
| ChEBI ID | 4670 |
| PubChem CID | 36811 |
| DrugBank | DB00841 |
| UNII ID | 3S12J47372 (ChemIDplus, GSRS) |
Target
Agency Approved
Alternate
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 20,078 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,671 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use